December 31, 2017 | December 31, 2016 | ||||||
Deferred tax assets: | |||||||
Federal net operating losses | $ | 187,003 | $ | 331,365 | |||
Tax credit carryforwards | 151,707 | 151,687 | |||||
State net operating losses and credits | 102,077 | 77,113 | |||||
Accrued liabilities | 22,771 | 37,163 | |||||
Deferred revenue | 22,699 | 26,256 | |||||
Equity-based compensation | 6,185 | 20,892 | |||||
Capital and other losses | 14,300 | 25,276 | |||||
Other | 10,541 | 15,876 | |||||
Gross deferred tax assets | 517,283 | 685,628 | |||||
Valuation allowance | (390,161 | ) | (428,778 | ) | |||
Net deferred tax assets | 127,122 | 256,850 | |||||
Deferred tax liabilities: | |||||||
Intangible assets | (175,731 | ) | (332,892 | ) | |||
Gross deferred tax liabilities | (175,731 | ) | (332,892 | ) | |||
Net deferred tax liabilities | $ | (48,609 | ) | $ | (76,042 | ) | |
December 31, 2017 | December 31, 2016 | ||||||
Other long-term assets | $ | 1,747 | $ | 1,412 | |||
Deferred tax liabilities, net | (50,356 | ) | (77,454 | ) | |||
Net deferred tax liabilities | $ | (48,609 | ) | $ | (76,042 | ) | |
Carryforward Amount | Years of Expiration | ||||
Federal | $ | 1,036,183 | 2019 - 2035 | ||
State | $ | 1,184,488 | 2019 - 2035 | ||
Carryforward Amount | Years of Expiration | ||||
Federal research and development credits | $ | 61,321 | 2018 - 2036 | ||
State research and development credits | $ | 61,735 | Indefinite | ||
Foreign tax credits | $ | 105,100 | 2018 - 2024 | ||
Year Ended December 31, | |||||||||||
2017 | 2016 | 2015 | |||||||||
Balance at beginning of period | $ | (428,778 | ) | $ | (449,694 | ) | $ | (409,559 | ) | ||
Additions | (66,578 | ) | (12,971 | ) | (57,902 | ) | |||||
Assumed in acquisition | — | (52,243 | ) | — | |||||||
Deductions resulting from business combination | 195 | 86,130 | — | ||||||||
Deductions resulting from Tax Act of 2017 | 105,000 | — | — | ||||||||
Other deductions, net | — | — | 17,767 | ||||||||
Balance at end of period | $ | (390,161 | ) | $ | (428,778 | ) | $ | (449,694 | ) | ||
Year Ended December 31, | |||||||||||
2017 | 2016 | 2015 | |||||||||
Balance at beginning of period | $ | 83,055 | $ | 60,346 | $ | 134,962 | |||||
Increases: | |||||||||||
Assumed in acquisition | 365 | 21,441 | — | ||||||||
Tax positions related to the current year | 6,263 | 1,032 | 963 | ||||||||
Tax positions related to prior years | 2,091 | 3,651 | 1,385 | ||||||||
Decreases: | |||||||||||
Tax positions related to prior years | (2,232 | ) | (1,047 | ) | (2,874 | ) | |||||
Tax Act of 2017 | (15,282 | ) | — | — | |||||||
Audit settlements | — | (161 | ) | (69,816 | ) | ||||||
Statute of limitations lapses | (1,242 | ) | (2,072 | ) | (3,690 | ) | |||||
Foreign currency | 62 | (135 | ) | (584 | ) | ||||||
Balance at end of period | $ | 73,080 | $ | 83,055 | $ | 60,346 | |||||
Year Ended December 31, | |||||||||||
2017 | 2016 | 2015 | |||||||||
United States | $ | (55,846 | ) | $ | (32,843 | ) | $ | (2,456 | ) | ||
Rest of the world | 7,611 | 8,407 | 11,919 | ||||||||
(Loss) income from continuing operations before income taxes | $ | (48,235 | ) | $ | (24,436 | ) | $ | 9,463 | |||
Year Ended December 31, | |||||||||||
2017 | 2016 | 2015 | |||||||||
Current: | |||||||||||
Federal | $ | — | $ | — | $ | — | |||||
State | 906 | 3,380 | (1,998 | ) | |||||||
Foreign | 16,329 | 20,952 | 11,132 | ||||||||
Total current income tax expense | 17,235 | 24,332 | 9,134 | ||||||||
Deferred: | |||||||||||
Federal | (24,579 | ) | (83,059 | ) | 2,081 | ||||||
State | (1,947 | ) | (2,875 | ) | 2,127 | ||||||
Foreign | (988 | ) | (83 | ) | 413 | ||||||
Total deferred income tax benefit (expense) | (27,514 | ) | (86,017 | ) | 4,621 | ||||||
Income tax (benefit) expense | $ | (10,279 | ) | $ | (61,685 | ) | $ | 13,755 | |||
Year Ended December 31, | |||||||||||
2017 | 2016 | 2015 | |||||||||
Federal income tax | $ | (16,882 | ) | $ | (8,553 | ) | $ | 3,312 | |||
State income tax, net of federal benefit | (397 | ) | 434 | 4,029 | |||||||
Foreign income tax rate differential | (748 | ) | (1,713 | ) | (2,992 | ) | |||||
Foreign withholding tax | 13,849 | 20,571 | 9,724 | ||||||||
Repatriation of foreign income, deemed and actual | 1,526 | 4,573 | 477 | ||||||||
Change in unrecognized tax benefits | (704 | ) | (1,203 | ) | (4,515 | ) | |||||
Change in valuation allowance | 12,511 | (81,614 | ) | 5,463 | |||||||
Equity-based compensation | (976 | ) | 2,696 | 1,972 | |||||||
Tax settlements | — | 166 | (3,437 | ) | |||||||
Transaction-related costs | 5,724 | 2,753 | — | ||||||||
Entity rationalization | 2,369 | — | — | ||||||||
Tax Act of 2017 | (26,551 | ) | — | — | |||||||
Other, net | — | 205 | (278 | ) | |||||||
Income tax (benefit) expense | $ | (10,279 | ) | $ | (61,685 | ) | $ | 13,755 | |||
• | Revaluation of deferred tax assets and liabilities: The Tax Act of 2017 reduces the U.S. federal corporate income tax rate from 35% to 21% for tax years beginning after December 31, 2017. In addition, the Tax Act of 2017 makes certain changes to the depreciation rules and implements new limits on the deductibility of certain executive compensation. The Company has evaluated these changes and recognized a provisional decrease to its net deferred tax assets of $105.0 million with a corresponding decrease to the deferred tax asset valuation allowance. The Company also recognized a provisional decrease to its deferred tax liabilities associated with indefinite-lived intangible assets of $26.6 million with a corresponding tax benefit. The Company is still completing its calculation of the impact of these changes on its deferred tax balances. |
• | Transition Tax on unrepatriated foreign earnings: The Transition Tax on unrepatriated foreign earnings is a tax on previously untaxed accumulated and current earnings and profits (“E&P”) of the Company’s foreign subsidiaries. Based on the amount of post-1986 E&P of the Company's foreign subsidiaries, as well as the amount of non-U.S. income taxes paid on such earnings, the Company estimates its Transition Tax to be $33.8 million, which is fully offset by net operating losses resulting in no estimated net Transition Tax expense. To complete its estimate of the Transition Tax, the Company must complete its calculation of E&P, complete its calculation of the effects on U.S. states whose laws conform with the Internal Revenue Code, determine whether to offset the Transition Tax with foreign tax credits, and make a final determination of historical non-U.S. income taxes paid and/or accrued. |
• | Limits on executive compensation: The Tax Act of 2017 imposes new limits on the deductibility of executive stock-based compensation. To determine the effect of the new limits, the Company must determine whether compensation resulting from agreements executed before the effective date of the Tax Act of 2017 are grandfathered by the Tax Act of 2017. The Company estimates the effect of the new limits was not material; however, the Company has not completed its analysis of state conformity with respect to these provisions of the Tax Act of 2017, including any effect on the apportionment of taxable income among the states in which it conducts business. |
• | Valuation allowance: The Company must assess whether its deferred tax asset valuation allowance is affected by various aspects of the Tax Act of 2017 (e.g., deemed repatriation of deferred foreign income, future GILTI inclusions, new categories of foreign tax credits). As the Company has recorded provisional amounts related to certain portions of the Tax Act of 2017, any corresponding change in the deferred tax asset valuation allowance is also provisional. However, the Company was able to determine that the Tax Act of 2017 does not change its assertion that its U.S. federal deferred tax assets are not more likely than not to be realized, thus the Company has maintained its deferred tax asset valuation allowance for U.S. federal deferred tax assets. |
• | Global intangible low taxed income (“GILTI”): The Tax Act of 2017 creates a new requirement that certain income (i.e., GILTI) earned by foreign subsidiaries must be included currently in the gross income of the U.S. shareholder. Due to the complexity of the GILTI rules, the Company continues to evaluate its accounting implications. Under U.S. GAAP, the Company is permitted to make an accounting policy election to either treat taxes due on future inclusions in U.S. taxable income related to GILTI as a current-period expense when incurred or to factor such amounts into the Company’s measurement of its deferred taxes. The Company has not yet completed its analysis of the GILTI rules and has not made an accounting policy election with respect to the treatment of the GILTI tax. |
• | Indefinite reinvestment assertion: Beginning in 2018, the Tax Act provides a 100% deduction for dividends received from 10-percent owned foreign corporations by U.S. corporate shareholders, subject to a one-year holding period. Although dividend income is now exempt from U.S. federal income tax, U.S. GAAP requires companies to account for the tax consequences of outside basis differences and other tax impacts of investments in non-U.S. subsidiaries. The Company accrued a liability for U.S. federal and certain state income taxes on its non-U.S. subsidiaries’ previously undistributed foreign earnings. While the Company has accrued the Transition Tax on the deemed repatriated earnings that were previously asserted to be indefinitely reinvested, additional outside basis differences likely exist, which could result in additional state income tax, foreign income tax and foreign withholding taxes if the amount equal to the outside basis difference were repatriated. Therefore, the Company was unable to determine a reasonable estimate of the remaining tax liability, if any, under the Tax Act of 2017 for its remaining outside basis differences or evaluate how the Tax Act of 2017 affects the Company’s existing accounting position to indefinitely reinvest unremitted foreign earnings. |